Hester Biosciences Limited has informed the Exchange about General Updates

Promoter Below 50pctOwnership Changes View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.6%1-day move

₹1749.00

prior close

₹1951.10

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.9+0.2+0.1-0.6+1.6+3.8+5.2+7.8+8.2+21.8+11.7+18.8+37.4—

Up moveDown movePending

AI summary

Hester Biosciences' Board has approved the submission of an application to NSE and BSE for re-classification of Mr. Ravin Gandhi and Ms. Bela Gandhi from the 'promoter' category to the 'public' category shareholders. This request was originally initiated by the two individuals. The Board noted that both individuals have confirmed compliance with conditions specified under Regulation 31A(3)(b) of SEBI LODR Regulations. The re-classification is subject to receipt of No Objection Certificate from the stock exchanges.

Likely market impact

Promoter group size will reduce following regulatory approval, which may affect the company's promoter holding percentage and shareholder structure. This could have implications for future acquisition rules and public shareholding compliance.